PharmacofMRI of Anxiolytic Medications (Pregabalin)

Completed · Phase 4 · Has a placebo group

Conditions studied: Anxiety Disorders

In brief

The purpose of this study is to use functional magnetic resonance imaging (fMRI) in healthy controls to examine the acute effects of certain anxiolytic medications on brain function. In this case, the medication pregabalin will be used. The investigators hypothesize that pregabalin (at doses of 50 mg and 200 mg, versus placebo) will yield a reduction in amygdala and insula activity (in a dose-dependent fashion) during emotion processing using fMRI.

Key facts

Study ID
NCT00706836
Run by
University of California, San Diego
People needed
16
Starts
2008-06-01
Expected to finish
2008-12-01
Last updated by the study team
2019-04-09

Who can join

Age: 18 and older, up to 30. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.